NERVMinerva Neurosciences, Inc.

$58M

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$1,361

Operating Income

-$3M

Net Income

-$3M

EPS (Diluted)

$-0.36

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$272,897

Balance Sheet

Total Assets

$28M

Total Liabilities

$63M

Stockholders' Equity

-$35M

Cash & Equivalents

$12M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$1,361	$0	—
Operating Income	-$3M	-$4M	+34.9%
Net Income	-$3M	$23M	-112.2%

NERV Q3 2025 Earnings — Minerva Neurosciences, Inc. Revenue & Financial Results | Market Cap Arena